Ventana launches fully automated Gram Stain on the BenchMark Special Stains platform

TUCSON, Ariz., Oct. 22, 2013  — Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the VENTANA Gram Staining Kit(1) . Automated for use on the VENTANA BenchMark Special Stains instrument, the Gram Staining Kit aids pathologists in the most basic classification of bacteria into Gram-positive and Gram-negative bacteria in fixed tissue samples. Gram stain classification is clinically useful as it provides an initial indication of the nature of a patient’s infection.

 

Gram positive and gram negative bacteria with green counterstain, stained using VENTANA Gram Staining Kit on the BenchMark Special Stains automated staining platform. (Image: Ventana Medical Systems, Inc.)

The Gram stain is part of a family of histochemical special stains that many laboratories around the world still run manually today. In automating the stain, Ventana gives its customers an efficient and automated method to perform this technically challenging assay, enabling them to achieve increased productivity, consistency, and testing quality.

“Tissue diagnostics play a critical role in enabling accurate diagnosis and treatment decisions for cancer patients. Ventana is dedicated to providing laboratories, pathologists and their patients with novel assays, and we are empowering our customers to achieve greater efficiencies by automating common, yet labor-intensive tests like the Gram stain,” says Mara G. Aspinall, President, Ventana Medical Systems, Inc.

The Gram Staining kit is the newest addition to the Ventana product offerings on the highly successful, fully automated BenchMark Special Stains platform launched in mid-2012. The kit offers two counterstain options and testing protocol flexibility to meet pathologists’ individual preferences.

“The new Gram Staining Kit will provide our customers visual consistency and clarity rarely achieved with manual Gram staining protocols. Our commitment to quality and advancing diagnostic consistency through world-class automation shines with this new product,” says Adrian Ralph, Vice President, Primary Staining, Ventana Medical Systems, Inc.

Learn more about Special Stains, and watch the BenchMark Special Stains Time lapse video here

(1) The VENTANA Gram Stain Kit is being launched as a US Class I exempt/ CE-IVD product.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. (“VMSI”) (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. VENTANA, the VENTANA logo, and BenchMark are trademarks of Roche.

Visit www.ventana.com to learn more.

VMSI Media Relations
Jacqueline Bucher
Senior Director, Corporate Communications
Phone: 520-877-7288
e-mail: Jacquie Bucher

SOURCE Ventana Medical Systems, Inc.

 

Help AZ develop a 21st Century Workforce

To address the current and future needs to develop a 21st Century Workforce, Arizona State University is teaming with the Maricopa Community Colleges and other 2-year schools in Arizona to establish educational programs that would supply the state’s industry with technicians or engineering assistants having specific high technology skills and knowledge.

 

As an industry, out  inputs towards the design of these programs are important, so we are surveying technology companies to learn more about skill sets that your firm will require in technicians or engineering assistants (both now and in the future).  In this survey, the skill sets being addressed pertain to micro- or nano-scale technologies used in manufacturing as well as research and development.

 

Survey link: http://surveys.questionpro.com/a/t/ABkVkZP44U

 

The survey should take less than 5 minutes to complete, and is designed for technical supervisory or management personnel.  Your participation is very much appreciated.  If you feel a colleague within your company is the more appropriate person to respond to this survey, please kindly forward this message.  It is also possible that some companies will receive more than one request due to different points of contact in the various databases we used to compile our mailing list.  We apologize for the duplication if that occurs.

 

Information obtained from each company will be held in the strictest confidence, and survey results will only be described in the aggregate.  If you have any questions, please contact:

 

Dr. Mangala Joshua Dr. Ray Tsui
Mesa Community College Arizona State University
480-461-7053 480-206-4736

 

ASU appoints Hao Yan as director of new Center for Molecular Design and Biomimicry

hao_yan.png

ASU Professor Hao Yan has been appointed as leader of a new effort to advance 21st century discoveries that will have a major impact on the fields of biomedicine, energy research and bioelectronics, called the Center for Molecular Design and Biomimicry (CMDB).

 

“With the formation of the first ASU Center entirely devoted to biomimicry, Hao Yan’s considerable leadership and expertise will serve as a major catalyst in developing a world-class research initiative that seeks to better understand nature’s design rules, and reimagine, reinterpret and rebuild them in a countless number of ingenious ways in order to make our lives better,” said ASU President Michael Crow.

“Starting as an ASU assistant professor just a decade ago, Hao Yan has had a meteoric rise through the academic ranks of ASU, and thrived in the multi-disciplinary atmosphere of the Biodesign Institute,” said Dr. Raymond DuBois, M.D., Ph.D., executive director of the Biodesign Institute.  “With his impressive body of work, extraordinary talents of the research team he has assembled, and the breakneck speed of their discoveries and achievements, he has had a profound impact on nanotechnology. Now, with the expansion of Hao Yan’s research in the establishment of this new Center, and the recruitment of more top-notch talent, we will significantly broaden the scope and influence of his research.”

The new CMDB becomes the 12th research center at ASU’s Biodesign Institute, and is emblematic of the Institute’s mission of scientists tackling complex societal issues by creating “bio-inspired” solutions to some of the world’s most urgent challenges in the areas of biomedicine and health outcomes, sustainability and national security.

“Now, with this Center, there is a golden opportunity to expand ASU’s research in  molecular design and biomimicry,” said Yan, who holds the inaugural Milton Glick Distinguished Professor of Chemistry and Biochemistry. “I am thankful to President Crow and ASU’s leadership for the opportunity to implement the vision of this new Center and develop a world-class biomimicry effort to benefit ASU, the state and ultimately society.”

Imitation of Life

In nature’s role as Earth’s master architect, an almost 4 billion-year trial-and-error process has refined all of our planet’s living organisms, functions and materials. Scientists have long looked at nature as inspiration for answers to both complex and simple problems throughout our existence, from Leonardo Da Vinci creating elaborate sketches of flying machines by studying birds in flight to more recent attempts to understand the properties of spiders’ silk to build materials as strong as Kevlar. The field of biomimicry has given rise to new technologies created from biologically-inspired engineering, ranging from nano-scale to macro-scale outcomes.

To date, Yan’s research approach has focused on using DNA, an essential building block of all life forms, as the architectural underpinnings of a biomimicry approach to advanced nanotechnology with the ultimate goal of building a suite of dynamic nanoscale devices.

Yan is a well-recognized leader in his field, known as structural DNA nanotechnology, or DNA origami, that can fold and self-assemble DNA into a broad range of technological applications important for human health and bio-electronic sensing devices.

 

This video, produced in collaboration with the National Science Foundation, describes the innovative process of DNA origami and some of the Yan group’s advances in this research domain.

In addition to his research team’s scientific achievements that have graced the covers of leading research journals such as Science and Nature, honors for Yan include: a $6.5 million Department of Defense MURI award, an Alfred P. Sloan Research Fellowship (2008-10), National Science Foundation CAREER Award (2006-2011), Air Force Office of Scientific Research Young Investigator Award (2007-2010), and the Arizona Technology Enterprise Innovator of Tomorrow Award (2006).

Yan’s inspiration behind the new Biomimicry Center is to move beyond DNA nanotechnology, and develop innovative technologies that may spark a ‘bottom up’ nanotechnology industry to develop novel solutions in medicine, energy and electronics. Such a field could spawn the growth of entirely new 21st century industries.

“I have always been very interested in designer architecture,” said Yan. “Every architect needs a set of design rules. In nanotechnology, we need a set of rules that will allow anyone in the field to be able to design an engineered biochemical pathway using a bottom-up approach, where we use the biochemical building blocks of a cell as our building blocks to make new discoveries.”

From bio-inspiration to innovation

Yan’s research team has built a variety of 2-D and 3-D structures at a scale 1,000 times smaller than a human hair, and now, he wants to push their efforts to build ever smaller, and design at the scale of individual atoms, molecules and chemical bonds, which he has dubbed “Angstrom level control.”

Support for the establishment of CMBD includes federal funding and funds from ASU’s Office of Knowledge Enterprise Development. As the center grows and matures, large collaborative grants with other universities and industrial partnerships will serve to accelerate discovery.

Major CMBD research thrusts include developing faculty labs devoted to all aspects of the biomimetic innovation cycle, including:

Design-employing computational methods to design, model and predict molecular behavior

Synthesis-making the building blocks and molecular “Lego” sets

Assembly-assembling building blocks into structures

Programming-thinking of biomimetic systems like the transistors, circuits and logic found in microprocessors and computer hardware

Biomimetic materials and systems engineering-integrating biomimetic materials with man-made systems to optimize functionality

“Our initiative will ultimately distinguish itself significantly from the majority of other biomimicry efforts around the world, where scientists develop biomimetic materials by identifying, adapting, and modifying existing biological components for subsequent integration with manmade materials,” said Yan. “Our vision is to design intelligent materials and processes, and a suite of smart molecules that can self-assemble into materials or function in biological networks to deliver drugs, control chemical reactions or build molecular scale electronics, as well as for tissue engineering, biosensors and renewable fuels.”

yangroup2012.png

Media contact:
Joe Caspermeyer
Media Relations & Managing Editor
480-727-0369
joseph.caspermeyer@asu.edu